RT
Last reporting period 31 Mar, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0
Exchange
OOTC - OTC
—
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Rapid Therapeutic
Company Analysis
RTSL valuation, rating, competitors, insights and company profile
Eyestock Rating
RTSL financial analysis by Eyestock methodology
Valuation
RTSL valuation using historical relative method
Statements
RTSL Income Statements, Balance Sheet and Cash Flow Statements
Dividends
RTSL dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Rapid Therapeutic`s Current ratio for the last twelve months ended 2023-03-31 is —
